Why the study?
Is minimally invasive coronary artery bypass grafting (MIDCAB) safe and effective for improving symptoms and graft flow in high-risk patients ineligible for conventional CABG?
Is minimally invasive coronary artery bypass grafting (MIDCAB) safe and effective for improving symptoms and graft flow in high-risk patients ineligible for conventional CABG?
MIDCAB is a safe and feasible revascularization strategy that improves symptoms and exercise tolerance in high-risk patients deemed inoperable for conventional CABG.
Supports MIDCAB feasibility in high-risk inoperable patients; hypothesis-generating and requires prospective validation.
UNLABELLED: Patients with significant risk factors are at increased risk of higher mortality and morbidity (9-16%) after CABG-procedures with cardiopulmonary bypass (CPB). When catheter interventions are not applicable and conventional CABG with CPB are considered to have an unacceptable perioperative risk, these patients (n=35) were scheduled for minimally invasive coronary artery bypass grafting (MIDCAB). PATIENTS AND METHODS: The risks leading to exclusion of conventional CABG procedures were: extremely impaired LV-function (EF<20%), severe pulmonary diseases, malignant carcinoma, compromised coagulation system, age >80 years with impaired physical constitution, redo-procedures after complicated initial operation, symptomatic descending thoracic aortic aneurysm, ongoing long-term intensive care treatment with unclear prognosis. All patients received the LIMA as a single graft to the LAD. One year follow-up was performed using transthoracic Doppler echocardiography at rest and during exercise. RESULTS: In 20 patients incomplete revascularization was accepted. There was no mortality, while signs for myocardial infarction were seen in two patients. Twenty-nine patients (82%) showed clear improvement of clinical symptoms, one patient needed further conventional CABG. Nine to thirteen months postoperatively (mean 10.8+/-1.6 months), there were two deaths due to noncardiac reasons. Three of the survivors (n=33) had symptoms of angina pectoris. Exercise tests revealed an improved stress tolerance (NYHA class improved from preop. III-IV to postop. I-II). The IMA graft flow increased significantly with exercise in all patients. Flow patterns in both flow velocity and volume changed to diastolic-dominant, and the ratio of diastolic to systolic time-velocity integral of >1.5 excluded a graft stenosis. CONCLUSIONS: In high-risk patients, with an increased likelihood of perioperative morbidity and mortality, the MIDCAB procedure can be performed accurately and safely. Even after incomplete revascularization of some high-risk patients, exercise tolerance was improved. Transthoracic Doppler echocardiography proved to be a clinically useful noninvasive method of assessing IMA graft function at rest and during exercise. Despite the small patient population, our late follow-up results suggest the potential benefit of MIDCAB for patients with otherwise inoperable heart disease.
No takes yet. Share an insight, caveat, or question.
U Sunderdiek (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: